Guangdong Hecin Scientific,Inc.

Provider of comprehensive respiratory infection diagnosis

Respiratory Health for All

View Details

Safeguard Human Respiratory Health

Accurate, Fast, Convenient

Hecin provides comprehensive and multi-platform
respiratory virus diagnostic products

Product & Service

Laboratory Instruments Fluorescence Immunochromatography Molecular Enzyme&RUO Test Kit PCR Test Kit(IVDD&NMPA) PCR Quality Control Covid 19 Solution

UltraFast qPCR InstrumentHC1600

Based on the principle of real-time fluorescence PCR detection, the HC1600 is a portable PCR system with 16 sample throughput, it is able to get fast result within 30 mins proceeding 16 samples per run.

View Details

Maverick qPCRAnitoa-Maverick qPCR

Manufacturer of In-Vitro diagnostic solution for respiratory disease

Who we are?

Guangdong Hecin Scientific, Inc.( Hecin )is a professional IVD company specializes in the cutting-edge research and development of respiratory infection diagnosis. With independent R&D and production site , we provide the most comprehensive diagnostic solution worldwide.

2015 year

Establish in

600 +

Example of virus strain

80 Million

Sales

View Details

Our Mission

Ensuring human respiratory health

Our Vision

Comprehensive provider of diagnostic solution for respiratory diseases

Our Value

Pursuing excellence, technology-oriented, honest and trustworthy, embrace responsibility with passion

News

Hecin Scientific is committed to ensuring human respiratory health, always adhering to the concept of independent research and innovation, and deeply dedicated in respiratory infectious diseases diagnosis

View Details

16 2023.02

Accurate diagnosis and treatment | flexible nucleic acid testing plan

Hecin's PCR multiplex detection makes diagnostic testing simpler and more effective than ever before, allowing for simultaneous detection of multiple targets, all of which are accomplished in one PCR test.

2023.02.16

04 2022.07

Focusing on accuracy and efficiency, Hecin nucleic acid detection is helpful to the global fight against novel coronavirus pneumonia

In order to help end the emergency phase of the novel coronavirus pneumonia epidemic, WHO calls on all countries to continue to strengthen their virus monitoring capabilities to detect early warning signals of major evolution of the virus, and nucleic acid detection is an important part of virus monitoring.

2022.07.04

31 2024.05

Epidemic strains of hand, foot and mouth disease virus are evolving

Recently, the China CDC Weekly Report released a research study on HFMD viruses, which showed that Coxsackievirus A6 (CV-A6) has become the major pathogen causing severe cases of HFMD in China. This finding is of widespread concern because Coxsackievirus A6, which is associated with severe HFMD, is evolving and is at risk for outbreaks.

2024.05.31